CL2009001564A1 - Vacuna contra el virus de la leucemia felina (felv) que comprende un adenovirus que contiene un gen del felv; adenovirus recombinante que comprende un adn del adenovirus del felv. - Google Patents

Vacuna contra el virus de la leucemia felina (felv) que comprende un adenovirus que contiene un gen del felv; adenovirus recombinante que comprende un adn del adenovirus del felv.

Info

Publication number
CL2009001564A1
CL2009001564A1 CL2009001564A CL2009001564A CL2009001564A1 CL 2009001564 A1 CL2009001564 A1 CL 2009001564A1 CL 2009001564 A CL2009001564 A CL 2009001564A CL 2009001564 A CL2009001564 A CL 2009001564A CL 2009001564 A1 CL2009001564 A1 CL 2009001564A1
Authority
CL
Chile
Prior art keywords
felv
adenovirus
vaccine
gene
leukemia virus
Prior art date
Application number
CL2009001564A
Other languages
English (en)
Inventor
Teshome Mebatsion
Perry Richard Linz
Jessica A Moore
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2009001564A1 publication Critical patent/CL2009001564A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacuna contra el virus de la leucemia felina (felv) que comprende un adenovirus que contiene un gen del felv; adenovirus recombinante que comprende un ADN del adenovirus del felv.
CL2009001564A 2008-07-11 2009-07-09 Vacuna contra el virus de la leucemia felina (felv) que comprende un adenovirus que contiene un gen del felv; adenovirus recombinante que comprende un adn del adenovirus del felv. CL2009001564A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7991508P 2008-07-11 2008-07-11

Publications (1)

Publication Number Publication Date
CL2009001564A1 true CL2009001564A1 (es) 2010-09-24

Family

ID=41057524

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001564A CL2009001564A1 (es) 2008-07-11 2009-07-09 Vacuna contra el virus de la leucemia felina (felv) que comprende un adenovirus que contiene un gen del felv; adenovirus recombinante que comprende un adn del adenovirus del felv.

Country Status (3)

Country Link
AR (1) AR072555A1 (es)
CL (1) CL2009001564A1 (es)
WO (1) WO2010004043A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1765387T1 (sl) * 2004-06-04 2013-04-30 Merial Limited Dajanje cepiv proti FeLV brez igle

Also Published As

Publication number Publication date
AR072555A1 (es) 2010-09-08
WO2010004043A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
MX2025011629A (es) Oligonucleotidos modificados dirigidos a snp
EA201491837A1 (ru) Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток
BRPI0919905A2 (pt) adesivo sensíveis à pressão de silicone não-funcionalizados, curados com feixe de elétrons
ES2683695T3 (es) Repeticiones terminales invertidas restrictivas para vectores virales
MX2013000315A (es) Molecula de acido nucleico de cadena simple para el control de la expresion de genes.
EP3795581A3 (en) New avv capsid proteins for nucleic acid transfer
EP2223086A4 (en) FLUORESCENT COMPOUNDS
PH12013500925B1 (en) North american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
EA201170591A1 (ru) Композиции и способы для ингибирования экспрессии транстиретина
BRPI0811755A2 (pt) Amplificação específica de senquência de dna específicas de tumor.
BRPI0918463A2 (pt) métodos para fabricar e para usar um instrumento endodôntico, e, instrumento endodôntico.
PH12014502534B1 (en) Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
CL2012000452A1 (es) Acido nucleico infeccioso de virus torque teno porcino (pttv), que comprende secuencia que codifica un pttv infeccioso con una secuencia genomica de pttv 1a-va; acido nucleico, plasmido y celula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
GB2461659A (en) Structured compositions comprising a clay
PE20131401A1 (es) Kit para detectar el virus de la leucemia bovina (blv), y uso del mismo
CL2011002913A1 (es) Plasmido novedoso con numero de acceso mtcc 5561; virus de vaccinia ankara modificado (mva) recombinante.
MX387400B (es) Células de mamífero que expresan antígenos de citomegalovirus.
WO2009153660A3 (en) Gene expression signatures for lung cancers
DK2179035T3 (da) Modificeret bakteriofag omfattende et alfa/beta-sasp-(small acid-soluble spore protein)-gen
AR070326A1 (es) Vectores de closterovirus y metodos relacionados
MX2009005817A (es) Agentes para combatir parasitos en animales.
CL2012002518A1 (es) Un portador de soporte de una estructura de soporte de una criba vibratoria, que posee por lo menos un elemento recto hecho de una sola pieza con por lo menos un parte espaciadora integrada.
MX2011005281A (es) Vacuna marcadora de salmonella.
IL230460A0 (en) A recombinant feline leukemia virus component containing an effective feline leukemia virus envelope gene
MX348430B (es) Proteinas derivadas de genes cry de bacillus thuringiensis.